Literature DB >> 6489732

Synergistic anticonvulsant effects of a GABA agonist and glycine.

N Seiler, S Sarhan.   

Abstract

Administration of muscimol to mice in subcutaneous doses between 0.34 and 1.25 mg/kg produced partial protection against 3-mercaptopropionic acid (MPA)-induced seizures. Glycine at a dose of 750 mg/kg (10 mmol/kg) protected 20% of the animals 45 min after its administration. Combined treatment with the two compounds gave a near to complete protection against MPA-induced seizures. These observations suggest that the concomitant enhancement of glycinergic and GABAergic activities amplify the anticonvulsant effect of these neuronal systems against seizures induced by impairment of GABA-mediated transmission.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489732     DOI: 10.1016/0306-3623(84)90018-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Comparative pharmacokinetic and pharmacodynamic analysis of phthaloyl glycine derivatives with potential antiepileptic activity.

Authors:  O abu Salach; S Hadad; A Haj-Yehia; S Sussan; M Bialer
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

2.  Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.

Authors:  S Hadad; M Bialer
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

Review 3.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.